Statistics for Tissue Regenix Group PLC (id:4085 TRX)

Valuation metrics

Market cap

41.65M

Enterprise value

38.09M

Trailing P/E (ttm)

-2,345.68

Forward P/E

0.75

PEG ratio

0.75

Price/Sales (ttm)

1.31

Price/Book (mrq)

134.98

Enterprise Value/Revenue

1.51

Enterprise Value/EBITDA

38.65

Overview

Shares outstanding

71.23M

Float

42.50M

Shares short

% Held by insiders

0.49%

% Held by institutions

0.38%

Average volume (10 days)

32.59K

Average volume (90 days)

Price summary

52-Week low

50.00

52-Week high

75.00

52-Week change

1.75%

Beta

1.58

50-Day moving average

57.40

200-Day moving average

62.83

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

April 28th, 2023

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

December 31th, 2023

Profitability

Profit margin

-3.46%

Operating margin

3.19%

Operational effectiveness

Return on assets

0.50%

Return on equity

-3.31%

Income statement

Revenue (ttm)

0.45

Revenue per share (ttm)

0.45

Quarterly revenue growth (yoy)

Gross profit (ttm)

14.04M

EBITDA

446.00K

Net income to common (ttm)

-874,447.00

Diluted EPS (ttm)

-0.01

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

2.75M

Total cash per share (mrq)

0.05

Total debt (mrq)

8.32M

Total Debt/Equity (mrq)

35.69

Current ratio (mrq)

374.10%

Book value per share (mrq)

0.43

Cash flow

Cash flow statement

284.33K

Levered free cash flow (LFCF)

-505,031.00